Bonhoeffer S - Search Results

1

COVID-19 infectivity profile correction.

Ashcroft P, Huisman JS, Lehtinen S, Bouman JA, Althaus CL, Regoes RR, Bonhoeffer S. Ashcroft P, et al. Among authors: bonhoeffer s. Swiss Med Wkly. 2020 Aug 5;150:w20336. doi: 10.4414/smw.2020.20336. eCollection 2020 Jul 27. Swiss Med Wkly. 2020. PMID: 32757177 Free article. No abstract available.

2

Evolution of virulence in a heterogeneous host population.

Regoes RR, Nowak MA, Bonhoeffer S. Regoes RR, et al. Among authors: bonhoeffer s. Evolution. 2000 Feb;54(1):64-71. doi: 10.1111/j.0014-3820.2000.tb00008.x. Evolution. 2000. PMID: 10937184

3

Contribution of peaks of virus load to simian immunodeficiency virus pathogenesis.

Regoes RR, Staprans SI, Feinberg MB, Bonhoeffer S. Regoes RR, et al. Among authors: bonhoeffer s. J Virol. 2002 Mar;76(5):2573-8. doi: 10.1128/jvi.76.5.2573-2578.2002. J Virol. 2002. PMID: 11836438 Free PMC article.

4

Dose-dependent infection rates of parasites produce the Allee effect in epidemiology.

Regoes RR, Ebert D, Bonhoeffer S. Regoes RR, et al. Among authors: bonhoeffer s. Proc Biol Sci. 2002 Feb 7;269(1488):271-9. doi: 10.1098/rspb.2001.1816. Proc Biol Sci. 2002. PMID: 11839196 Free PMC article.

5

HIV coreceptor usage and drug treatment.

Regoes R, Bonhoeffer S. Regoes R, et al. Among authors: bonhoeffer s. J Theor Biol. 2002 Aug 21;217(4):443-57. doi: 10.1006/jtbi.2002.3049. J Theor Biol. 2002. PMID: 12234752

6

Recombination in HIV and the evolution of drug resistance: for better or for worse?

Bretscher MT, Althaus CL, Müller V, Bonhoeffer S. Bretscher MT, et al. Among authors: bonhoeffer s. Bioessays. 2004 Feb;26(2):180-8. doi: 10.1002/bies.10386. Bioessays. 2004. PMID: 14745836

7

The HIV coreceptor switch: a population dynamical perspective.

Regoes RR, Bonhoeffer S. Regoes RR, et al. Among authors: bonhoeffer s. Trends Microbiol. 2005 Jun;13(6):269-77. doi: 10.1016/j.tim.2005.04.005. Trends Microbiol. 2005. PMID: 15936659 Review.

8

Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1.

Althaus CL, Bonhoeffer S. Althaus CL, et al. Among authors: bonhoeffer s. J Virol. 2005 Nov;79(21):13572-8. doi: 10.1128/JVI.79.21.13572-13578.2005. J Virol. 2005. PMID: 16227277 Free PMC article.

9

Emergence of drug-resistant influenza virus: population dynamical considerations.

Regoes RR, Bonhoeffer S. Regoes RR, et al. Among authors: bonhoeffer s. Science. 2006 Apr 21;312(5772):389-91. doi: 10.1126/science.1122947. Science. 2006. PMID: 16627735

10

Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis.

Regoes RR, Bowen EF, Cope AV, Gor D, Hassan-Walker AF, Prentice HG, Johnson MA, Sweny P, Burroughs AK, Griffiths PD, Bonhoeffer S, Emery VC. Regoes RR, et al. Among authors: bonhoeffer s. Proc Biol Sci. 2006 Aug 7;273(1596):1961-7. doi: 10.1098/rspb.2006.3506. Proc Biol Sci. 2006. PMID: 16822758 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page